Previous Article | Next Article ![]()
J. Virol., Jan 1997, 75-83, Vol 71, No. 1
DM D'Agostino, V Ciminale, L Zotti, A Rosato and L Chieco-Bianchi
The X region of human T-cell lymphotropic virus type 1 (HTLV-1) encodes two
nucleolar/nuclear proteins, the posttranscriptional regulator of mRNA
expression Rex and a protein of unknown function named Tof. To gain insight
into the possible biological role of Tof, we investigated the mechanism
governing its intracellular trafficking and identified its
nucleolar/nuclear localization signal (NLS). Mutational analysis of Tof
revealed that its NLS was located between amino acids 71 and 98 and
contained two arginine-rich domains that functioned in an interdependent
manner. Studies of Tof-Rex hybrid proteins showed that the Tof NLS could
functionally replace the NLS of Rex at the level of nuclear targeting. As
the NLS of Rex is known to mediate its interaction with its RNA target, the
Rex-responsive element (RXRE), we tested whether the NLS of Tof could
replace that of Rex in mediating activation of a RXRE-containing mRNA.
Results showed that the NLS of Tof was indeed able to mediate activation of
RXRE-containing mRNAs, suggesting that Tof itself may function as a
regulator of RNA expression and utilization. A comparison of their
compartmentalization in response to actinomycin D treatment indicated that
Tof did not share Rex's shuttling pathway. Expression of Tof from its
natural multiply spliced mRNA required the presence of Rex, suggesting that
Tof may regulate viral or cellular mRNA expression during the later stages
of viral replication.
Copyright © 1997, American Society for Microbiology
The human T-cell lymphotropic virus type 1 Tof protein contains a bipartite nuclear localization signal that is able to functionally replace the amino-terminal domain of Rex
Department of Oncology and Surgical Sciences, University of Padua, Italy. dmdago@ipdunidx.unipd.it
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|